NLRP3 and cancer: Moreover, it is notable that pharmacological manipulation of NLRP3 inflammasomes has received attention as a potential therapeutic intervention against cancer and multiple inflammatory diseases46–49; whereas our study suggests a possible risk with this strategy: the inhibition of NLPR3 upstream modulators in mitochondria may lead to mitochondrial dysfunction that could drive brain calcification.